Afinitor Drug Market Trends, Research Report, Growth, Opportunities, Forecast 2021-2027

Orion Market Research

Afinitor Drug Market Report 2021: By Key Players, Application, Type, Share and Forecast 2021-2027 Request a free sample of our report on Afinitor Drug Market: https://www.omrglobal.com/requestsample/afinitor-drug-market

-----------------------------------------------------------------------------------Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

The global Afinitor drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor for the growth of the market is the increase in the number of organ transplants and rising incidences of chronic diseases such as cancer. According to the US Health Resources and Services Administration, in 2020, nearly 39,000 organ transplants were performed in the US. With the increasing prevalence of chronic diseases such as kidney disease and liver disease, there is high demand for organ transplantation. Every 9 minutes, a new person is added to the transplant waiting list. Therefore, the demand for the Afinitor drugs is growing significantly which is an immunosuppressant used after the organ transplantation procedure is performed.

A full report of Afinitor Drug Market is available at: https://www.omrglobal.com/industryreports/afinitor-drug-market The Afinitor drug is also used for the treatment of cancer. The active substance present is known as everolimus that blocks the mammalian target of rapamycin mTOR. It forms a complex with the FKBP-12 protein which in turn, blocks the mTOR. mTOR is present inside the cell and supports cell division by blocking off the mTOR and the cancer spread slows down. This drug is used in the treatment of various cancers which include breast cancer, pancreatic neuroendocrine tumours, renal cell carcinoma, and many others. Afinitor was launched by Novartis in 2009, after the approval of the US FDA. In 2019, Novartis reported nearly $1 billion in sales of Afinitor. Many generic drugs maker have started making the generics for the drugs as the patent has expired. In December 2019, the US FDA approved the first two generics of Novartis’ cancer drug Afinitor (everolimus) by Par Pharmaceuticals and Teva Pharmaceutical Industries Ltd. Both companies gained approval for everolimus tablets in 2.5 mg, 5, mg, and 7mg doses. Teva also picked up an additional approval for the drug in a 10 mg dose.

To learn more about this report request a sample copy @ https://www.omrglobal.com/requestsample/afinitor-drug-market Market Coverage    

The market number available for – 2020-2027 Base year- 2020 Forecast period- 2021-2027 Segment Covered-

o

By Type

o

By Application



Regions Covered

o

North America

o

Europe

o

Asia-Pacific

o

Rest of the Word 

Competitive Landscape – Novartis International AG, Teva Pharmaceuticals Industries Ltd., and more.

Key questions addressed by the report    

What is the market growth rate?

Which segment and region dominates the market in base year?

Which segment and region will project fastest growth in the market?

How COVID-19 impacted the market?

o

Recovery Timeline

o

Deviation from pre-COVID forecast

o

Most affected region and segment   

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Afinitor Drug Market

By Type    

2.5 mg 5 mg 7 mg 10 mg

By Application   

Hospitals Drug Stores Others

For more customized data, request for report customization @ https://www.omrglobal.com/reportcustomization/afinitor-drug-market Afinitor Drug Market– Segment by Region North America  

United States Canada

Europe      

Germany United Kingdom France Spain Italy Rest of Europe

Asia-Pacific    

China Japan India Rest of Asia-Pacific

Rest of the World  

Middle East & Africa Latin America

Company Profiles  

Novartis International AG Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us – 1.

2.

3.

4.

We cover more than 15 major industries, further segmented into more than 90 sectors.

More than 120 countries are for analysis.

Over 100+ paid data sources mined for investigation.

Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404